The Deputy Chief Medical Officer led a press conference on Wednesday to announce moves by the Medicines and Healthcare products Regulatory Agency (MHRA) to alter the advice on the Oxford manufactured vaccine. Following an MHRA investigation into the AstraZeneca jab and potential links with
